Montair LC
Generic: Montelukast/Levocetirizineby Cipla Limited

Select pack size
Similar medicines
View allAbout Montair LC
Montair LC is an Indian combination tablet from Cipla that contains two medicines: montelukast 10 mg, a leukotriene receptor antagonist, and levocetirizine 5 mg, an antihistamine. In India it is approved for allergic rhinitis (hay fever and year round nasal allergy) in adults. We sell Montair LC in packs of 30, 60 and 90 tablets, from $1.07 a tablet before shipping in the 90 pack.
Read these four points before you buy. One: no montelukast plus levocetirizine combination tablet is approved in the US, UK, Australia or Canada, as far as we could check: we found none in the FDA and Health Canada databases or on the UK emc, and no sign of one in Australia (we could not search the TGA register directly). Each ingredient is licensed on its own in the US, UK and Australia, and montelukast in Canada. Two: montelukast carries a US boxed warning for serious neuropsychiatric events, including suicidal thoughts and behaviour, and the FDA says that for allergic rhinitis it should be reserved for people who have not done well on other allergy medicines or cannot tolerate them. So this is not a first choice tablet for hay fever. Three: the levocetirizine half is fixed at 5 mg, so people with reduced kidney function, and children, usually need a different product. Four: in the US the two ingredients bought separately cost a pharmacy about 10 cents a day in total, far less than ours. This page sets out what the US, UK and Indian sources say, all listed at the end.
Montair LC at a glance
| Active ingredients | Montelukast 10 mg (as montelukast sodium) and levocetirizine dihydrochloride 5 mg per tablet (Tata 1mg, Truemeds, PharmEasy) |
| Brand and maker | Montair LC, Cipla Ltd, Mumbai (Truemeds gives Cipla House, Lower Parel; Tata 1mg names Cipla Ltd as marketer). Indian strips hold 15 tablets (10 tablet strips are also listed) |
| Regulatory status | India: montelukast 10 mg + levocetirizine 5 mg film coated tablets approved on 31.01.2008 "for the treatment of allergic rhinitis in adults only" (CDSCO). The combination is not approved by the FDA, MHRA, TGA or Health Canada (see Prescription and legal status for what we checked). This Indian pack is not registered in any of those countries |
| Usual dose | One tablet once a day, in line with the single ingredient labels (montelukast 10 mg once daily; levocetirizine 5 mg once daily in the evening). No more than one tablet in 24 hours |
| Timing | Levocetirizine peaks about 0.9 hour after a tablet and has a half-life of about 8 hours in adults (peak: US Xyzal label 12.3; half-life: UK Xyzal label 5.2). Montelukast peaks 3 to 4 hours after a 10 mg tablet (US Singulair label 12.3) |
| Packs | 30, 60 and 90 tablets: 30, 60 and 90 days at one tablet a day |
| Price per tablet | $1.50 (30), $1.27 (60), $1.07 (90), before shipping |
| Delivery | 7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149 |
What Montair LC is for, and what it is not for
The Indian regulator (CDSCO) approved this exact combination, montelukast 10 mg with levocetirizine 5 mg film coated tablets, "For the treatment of allergic rhinitis in adults only" (approval dated 31.01.2008). Allergic rhinitis means sneezing, a runny, itchy or blocked nose and itchy, watery eyes caused by allergy to pollen, dust mites, animal dander or moulds.
Each ingredient works in a different way. Levocetirizine blocks histamine at H1 receptors; the US Xyzal Allergy 24HR label says it "temporarily relieves these symptoms due to hay fever or other respiratory allergies: runny nose, sneezing, itchy, watery eyes, itching of the nose or throat". Montelukast blocks cysteinyl leukotrienes; in the US it is approved for asthma, exercise induced bronchoconstriction and allergic rhinitis, and in the UK the 10 mg tablet is licensed as an add on asthma treatment, with relief of seasonal allergic rhinitis only "In those asthmatic patients in whom Singulair is indicated in asthma" (UK Singulair 10 mg label 4.1).
Asthma is not part of the Indian approval for the combination tablet. Montair LC is not a reliever: montelukast is not indicated for an acute asthma attack (US label 1.4 and 5.2), and the UK label says "Patients should be advised never to use oral montelukast to treat acute asthma attacks". If you have asthma, keep your reliever inhaler and your preventer as your doctor prescribed, and do not stop an inhaled steroid to take this tablet: montelukast "should not be abruptly substituted for inhaled or oral corticosteroids" (US label 5.3).
Does the combination work better than one medicine? A 2026 meta-analysis of seven randomised trials with 887 people (Kim, PMID 40664175) found more improvement in daytime symptoms, runny nose and blocked nose with the combination than with montelukast or levocetirizine alone (pooled comparison), and similar rates of adverse events; quality of life scores did not differ in the subgroup comparisons with each single medicine. These were mostly small trials. In the US label's own trials, montelukast alone gave a modest effect on hay fever: in one seasonal allergic rhinitis trial the daytime nasal symptom score fell by 0.39 points with montelukast and 0.26 with placebo on a 0 to 3 scale, and loratadine fell by 0.46 (the trial was not designed to compare montelukast with loratadine; US label 14.3, Table 9).
Price per tablet
Prices below are as of October 2026; the pack selector shows the current price.
| Pack | Price | Per tablet | Shipping | Per tablet with shipping |
|---|---|---|---|---|
| 30 tablets | $45.00 | $1.50 | $25 | $2.33 |
| 60 tablets | $76.00 | $1.27 | $25 | $1.68 |
| 90 tablets | $96.00 | $1.07 | $25 | $1.34 |
The larger packs are cheaper per tablet before shipping as well as after it. All three packs are under the $149 free shipping line, so a single pack carries $25 shipping. At one tablet a day the packs last 30, 60 and 90 days (our arithmetic). Indian strips hold 15 tablets, so a 30 pack would usually be two strips; we have not confirmed how each order is packed.
Compared with US Singulair, Xyzal and US generics
| Montair LC (ours) | US generic montelukast 10 mg + generic levocetirizine 5 mg, bought separately | US Singulair 10 mg | |
|---|---|---|---|
| Maker | Cipla (India) | Several makers | Organon |
| FDA approved | No (no FDA approved montelukast plus levocetirizine combination exists) | Yes, each one on its own | Yes (NDA 020829) |
| Prescription in the US | Not applicable | Montelukast: prescription. Levocetirizine 5 mg: over the counter (Xyzal Allergy 24HR and store brands) | Prescription |
| Pharmacy cost (NADAC) per day | Not applicable | Montelukast 10 mg $0.04321 + levocetirizine 5 mg $0.05175 = about $0.09 to $0.10 a day (a few levocetirizine NDCs are $0.21841) | $9.22717 per tablet |
| Our price | $1.07 to $1.50 per tablet before shipping |
NADAC is the average price US pharmacies pay to buy a medicine, published by the US Medicaid programme; it is not the price a patient pays at the counter. The figures are from the NADAC file dated 28 October 2026: 31 generic montelukast 10 mg tablet NDCs at $0.04321, 8 generic levocetirizine 5 mg tablet NDCs at $0.05175 and 4 at $0.21841, and 2 Singulair 10 mg NDCs at $9.22717, all effective 21 October 2026. The levocetirizine rows are prescription-labelled generic tablets; over the counter store brands are priced separately.
The plain answer for US readers: generic montelukast 10 mg and generic levocetirizine 5 mg together cost a US pharmacy less than a tenth of what one Montair LC tablet costs from us (at the most common NADAC prices; our arithmetic), levocetirizine needs no prescription, and taking them as two tablets lets your doctor adjust or stop either one on its own (for example if you develop mood or sleep changes on montelukast, or if your kidney function means you need less levocetirizine). If you have a US prescription for montelukast, compare US cash prices first. In the UK, Canada and Australia, ask your doctor or pharmacist about locally licensed products first. We have not seen data comparing the Indian Montair LC tablet with US or UK products.
Which strength to choose
| Product | What it contains | What the labels say about this dose |
|---|---|---|
| Montair LC (this page) | Montelukast 10 mg + levocetirizine 5 mg | CDSCO: adults only. Montelukast 10 mg tablet: age 15 and over (US Singulair 2.1 and 2.3; UK 4.2 "Do not give Singulair 10 mg film-coated tablets to children less than 15 years of age"). Levocetirizine 5 mg: the US adult dose is 5 mg once daily in the evening (age 12 to 64; 65 and over ask a doctor) |
| Montair LC Kid (children's tablet) | Montelukast 4 mg + levocetirizine 2.5 mg | For children; dosing is a decision for the child's doctor. This page does not cover it |
| Montair 10mg | Montelukast 10 mg alone | US and UK adult and adolescent (15 and over) dose of montelukast |
| Montair 4mg Chewable Tablet | Montelukast 4 mg alone | US: children 2 to 5 years |
One Montair LC tablet a day is the whole daily dose of both medicines. Do not take it together with another montelukast product or another antihistamine unless a doctor tells you to: the UK label says Singulair "should not be used concomitantly with other products containing the same active ingredient, montelukast". The US Drug Facts for levocetirizine say "do not take more than 1 tablet (5 mg) in 24 hours", and that "½ tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms"; a combination tablet cannot give that lower dose without also halving the montelukast, which is not a labelled montelukast dose for adults.
How to take Montair LC
- Once a day, in the evening. Levocetirizine is labelled for once daily use in the evening (US Drug Facts). Montelukast for allergic rhinitis can be taken at any time of day, but people with both asthma and allergic rhinitis should take "only one SINGULAIR dose orally once daily in the evening" (US label 2.4). An evening dose fits both labels (our reading).
- With or without food. Both single ingredient labels allow this (US Singulair 2.3; UK Xyzal 4.2). Swallow the tablet whole with water (UK Xyzal 4.2).
- Missed dose. "Patients who miss a dose should take the next dose at their regular time and should not take 2 doses at the same time" (US Singulair 2.3).
- How long. The UK levocetirizine label says intermittent allergic rhinitis can be treated until symptoms go and restarted when they come back, and that for persistent allergic rhinitis continuous treatment "can be proposed to the patient during the period of exposure to allergens" (UK Xyzal 4.2). The FDA has asked doctors to weigh montelukast's mental health risks before prescribing it for allergic rhinitis at all, so a long course should be agreed with your doctor (our advice).
- Allergy skin tests. Antihistamines block allergy skin test results; the UK levocetirizine label says "a wash-out period (of 3 days) is required before performing them" (UK Xyzal 4.4).
- Stopping after long use. Itching can start within a few days of stopping levocetirizine after months or years of use, sometimes severe (US Xyzal 5.3; UK Xyzal 4.4). Tell your doctor if this happens.
Kidney problems, children, older age and pregnancy
- Kidney problems. Levocetirizine is cleared by the kidneys. The US Xyzal Allergy 24HR Drug Facts say "do not use" if you have kidney disease. The US prescription label recommends 2.5 mg once daily in mild kidney impairment (creatinine clearance 50 to 80 mL/min), 2.5 mg every other day in moderate and 2.5 mg twice weekly in severe impairment, and says people with end stage kidney disease or on haemodialysis "should not receive XYZAL" (US Xyzal 2.2, 4.2). The UK label keeps 5 mg daily down to an eGFR of 60, then gives 5 mg every 2 days (eGFR 30 to under 60) or every 3 days (15 to under 30), and contraindicates it below 15 (UK Xyzal 4.2, 4.3). A combination tablet cannot be spaced out like this without also spacing out the montelukast, so Montair LC is not suitable for people with moderate or severe kidney impairment, or for anyone on dialysis; in the US, the OTC label says not to use levocetirizine at all with kidney disease (our reading of these labels). Montelukast itself needs no kidney dose change (US Singulair 8.7).
- Children. Montair LC is not for children. The Indian approval is for adults only; the montelukast 10 mg tablet is for age 15 and over; levocetirizine Drug Facts say "children under 6 years of age: do not use" and limit children 6 to 11 to 2.5 mg, because a 5 mg dose gives about twice the adult exposure in that age group (US Xyzal 8.4). The US prescription label contraindicates levocetirizine in children 6 months to 11 years with impaired kidney function (US Xyzal 4.3).
- Age 65 and over. US levocetirizine Drug Facts: "adults 65 years of age and older: ask a doctor". The UK label advises dose adjustment in older people with moderate to severe kidney impairment. No age dose change is needed for montelukast (US Singulair 8.5).
- Liver disease. No montelukast dose change is needed in mild to moderate liver impairment; there are no data in severe liver impairment (UK Singulair 4.2). Levocetirizine needs no change for liver impairment alone, but the dose should be adjusted if kidney function is also reduced (US Xyzal 2.2; UK Xyzal 4.2).
- Pregnancy. UK Singulair 4.6: it "may be used during pregnancy only if it is considered to be clearly essential". UK Xyzal 4.6: "The use of levocetirizine may be considered during pregnancy, if necessary." US Drug Facts for levocetirizine: "if pregnant: ask a health professional before use". Talk to your doctor before taking it if you are pregnant or planning a pregnancy.
- Breastfeeding. US levocetirizine Drug Facts: "if breast-feeding: not recommended". UK Singulair 4.6: it "may be used in breast-feeding only if it is considered to be clearly essential". UK Xyzal 4.6: adverse reactions may be seen in breastfed infants and "caution should be exercised".
- Lactose. Both UK labels say that people with rare hereditary problems of galactose intolerance, lactase deficiency or glucose-galactose malabsorption "should not take this medicine". We have not seen the Montair LC ingredient list; ask us or read the carton.
Mood, behaviour and sleep: the montelukast warning
The US Singulair label opens with a boxed warning. Its key sentences, quoted exactly: "Serious neuropsychiatric (NP) events have been reported with the use of SINGULAIR. The types of events reported were highly variable, and included, but were not limited to, agitation, aggression, depression, sleep disturbances, suicidal thoughts and behavior (including suicide)." "Because of the risk of NP events, the benefits of SINGULAIR may not outweigh the risks in some patients, particularly when the symptoms of disease may be mild and adequately treated with alternative therapies. Reserve use of SINGULAIR for patients with allergic rhinitis who have an inadequate response or intolerance to alternative therapies." "If changes in behavior are observed, or if new NP symptoms or suicidal thoughts and/or behavior occur, advise patients to discontinue SINGULAIR and contact a healthcare provider immediately."
The FDA announced on 4 March 2020 that it was requiring the boxed warning. Its safety communication says: "For allergic rhinitis, also known as hay fever, we have determined that montelukast should be reserved for those who are not treated effectively with or cannot tolerate other allergy medicines." It also says montelukast "should not be the first choice treatment particularly when allergic rhinitis symptoms are mild."
The US label (5.1) adds that these events have been reported in adults, adolescents and children, with and without a previous psychiatric history, mostly during treatment but some after stopping, and that "in some cases symptoms persisted after discontinuation". The full list there includes anxiousness, disorientation, disturbance in attention, dream abnormalities, stuttering, hallucinations, insomnia, irritability, memory impairment, obsessive-compulsive symptoms, restlessness, sleepwalking, tic and tremor.
In the UK, the MHRA Drug Safety Update of 29 April 2024 says the warnings in the UK leaflet and product information "have been strengthened and highlighted with a black box for greater emphasis". It tells doctors to "discontinue montelukast if patients experience new or worsening symptoms of neuropsychiatric reactions", and tells patients: "you should seek immediate medical attention if you or your child experiences these symptoms; your prescriber is best placed to advise you on stopping this medicine if needed". The MHRA also asks doctors to tell patients to let friends and family know that they are taking montelukast. Levocetirizine has its own post-marketing reports of aggression, agitation, depression, hallucinations, insomnia, nightmares and suicidal ideation (US Xyzal 6.2).
Our own position: given the FDA's advice, Montair LC should not be anyone's first treatment for hay fever. Use it only if a doctor has advised montelukast after other allergy treatments did not work or were not tolerated. We cover the trial data and reports in more detail in our guide to montelukast side effects.
Other side effects
There are no US or UK label data for the combination tablet, so the tables below come from each single ingredient label. Both are selected tables: they leave out other rows and age groups in those labels.
| Adverse reaction | Levocetirizine 5 mg (n = 1070) | Placebo (n = 912) |
|---|---|---|
| Somnolence | 6% | 2% |
| Nasopharyngitis | 4% | 3% |
| Fatigue | 4% | 2% |
| Dry mouth | 2% | 1% |
| Pharyngitis | 1% | 1% |
| Adverse reaction | Montelukast 10 mg (n = 1955) | Placebo (n = 1180) |
|---|---|---|
| Headache | 18.4% | 18.1% |
| Influenza | 4.2% | 3.9% |
| Abdominal pain | 2.9% | 2.5% |
| Cough | 2.7% | 2.4% |
| Dyspepsia | 2.1% | 1.1% |
| Dizziness | 1.9% | 1.4% |
| Asthenia/fatigue | 1.8% | 1.2% |
| Rash | 1.6% | 1.2% |
Drowsiness, alcohol and driving. Somnolence with levocetirizine "showed dose ordering" between 2.5, 5 and 10 mg (US Xyzal 6.1). The US Drug Facts say "drowsiness may occur", "avoid alcoholic drinks", "alcohol, sedatives, and tranquilizers may increase drowsiness" and "be careful when driving a motor vehicle or operating machinery". The US prescription label says use with alcohol or other central nervous system depressants "should be avoided" (5.1). The UK montelukast label says individuals have reported drowsiness or dizziness (4.7). Check how the tablet affects you before you drive.
Urinary retention. Levocetirizine "should be used with caution in patients with predisposing factors of urinary retention (e.g. spinal cord lesion, prostatic hyperplasia)" and should be stopped if urinary retention occurs (US Xyzal 5.2). Drug Facts: ask a doctor first if you have ever had trouble urinating or emptying your bladder.
Seizures. The UK levocetirizine label advises caution in epilepsy and in people at risk of convulsions, "as levocetirizine may cause seizure aggravation" (UK Xyzal 4.4). Seizures are listed as an uncommon reaction to montelukast in the UK label (4.8).
Reported after marketing (frequency not known, US labels): with montelukast, allergic reactions including anaphylaxis, cholestatic hepatitis and other liver injury, Stevens-Johnson syndrome and toxic epidermal necrolysis, erythema multiforme, low platelets and increased bleeding tendency, palpitations, pancreatitis, nosebleeds and pulmonary eosinophilia (US Singulair 6.2); with levocetirizine, anaphylaxis, angioedema, hepatitis, palpitations and fast heartbeat, blurred vision, seizures and fixed drug eruption (US Xyzal 6.2). In people with asthma on montelukast, systemic eosinophilia, sometimes with features of vasculitis consistent with Churg-Strauss syndrome, has been reported; doctors are told to watch for "eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy" (US Singulair 5.5).
When to get urgent help
Call emergency services (911 in the US and Canada, 999 in the UK, 000 in Australia), or ask someone to call for you, if you have:
- Thoughts of harming yourself or suicide, or a sudden change in behaviour such as aggression, hallucinations or confusion. The US label says to stop the medicine and "contact a healthcare provider immediately"; the MHRA says "seek immediate medical attention". In the US you can also call or text 988 (Suicide and Crisis Lifeline); in the UK, Samaritans on 116 123; in Australia, Lifeline on 13 11 14; in Canada, 9-8-8 (numbers added by us).
- Signs of a severe allergic reaction: swelling of the face, lips, tongue or throat, trouble breathing or swallowing, hives or a spreading rash, or blistering or peeling skin. Levocetirizine Drug Facts: if an allergic reaction to this product occurs, "Seek medical help right away."
- An asthma attack that your reliever inhaler does not control. Montair LC does not treat an attack (US Singulair 5.2).
- Taking more than one tablet in 24 hours, or a child swallowing tablets. Drug Facts: "In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222)" (Australia: 13 11 26, added by us). Levocetirizine overdose may cause drowsiness in adults, and agitation and restlessness followed by drowsiness in children (US Xyzal 10).
Contact a doctor the same day (our advice) if you notice yellow skin or eyes, dark urine or pain under the right ribs (possible liver injury), unusual bruising or bleeding, a rash with numbness, tingling or worsening breathing, or you cannot pass urine. Tell the emergency staff that you took montelukast and levocetirizine (Montair LC), how much and when.
Who should not take Montair LC
Never take it if:
- you have ever had an allergic reaction to montelukast or any ingredient of the tablet (US Singulair 4; UK Singulair 4.3)
- you have ever had an allergic reaction to levocetirizine or cetirizine (US Xyzal 4.1 and Drug Facts), or also hydroxyzine or any other piperazine derivative (UK Xyzal 4.3)
- you have end stage kidney disease or are on dialysis (US Xyzal 4.2: creatinine clearance below 10 mL/min or haemodialysis; UK Xyzal 4.3: eGFR below 15 mL/min, requiring dialysis)
Do not use it, or ask a doctor first:
- children: the Indian approval is for adults only, and the US and UK montelukast 10 mg tablet is for age 15 and over; levocetirizine Drug Facts say "do not use" under 6 years
- any kidney disease: "do not use" (US levocetirizine Drug Facts); see the kidney section above
- a history of depression, anxiety, other mental health problems or suicidal thoughts: discuss the boxed warning with your doctor first (the US label says events have occurred with and without such a history)
- hay fever that has not yet been treated with a standard antihistamine or a steroid nasal spray: the FDA says montelukast should be reserved for people who did not respond to or could not tolerate other allergy medicines
- asthma: do not use it in place of your inhaled steroid or reliever (US Singulair 5.2, 5.3); people with aspirin sensitive asthma must still avoid aspirin and other NSAIDs (US 5.4; UK 4.4)
- trouble passing urine, an enlarged prostate or a spinal cord lesion (US Xyzal 5.2)
- epilepsy or a risk of seizures (UK Xyzal 4.4)
- age 65 and over, pregnancy or breastfeeding: ask a doctor or pharmacist first (US Drug Facts); breastfeeding is "not recommended" in the levocetirizine Drug Facts
- galactose intolerance, lactase deficiency or glucose-galactose malabsorption (UK labels 4.4)
Medicines and drinks that interact
- Alcohol, sedatives, sleeping tablets and other medicines that cause drowsiness: may add to drowsiness (US Xyzal 5.1; UK Xyzal 4.5; US Drug Facts).
- Other montelukast products: do not double up (UK Singulair 4.2). Other antihistamines: ask your doctor before combining them (our advice).
- Phenobarbital, phenytoin and rifampicin: phenobarbital cut montelukast exposure by about 40%, and the UK label says caution should be exercised with these enzyme inducers (UK Singulair 4.5).
- Gemfibrozil: raised montelukast exposure 4.4 fold; no routine dose change, but the doctor "should be aware of the potential for an increase in adverse reactions" (UK Singulair 4.5).
- Ritonavir: increased cetirizine exposure by about 42% (US Xyzal 7.2). Theophylline 400 mg reduced cetirizine clearance by about 16% (US Xyzal 7.1).
Tell your doctor and pharmacist about every medicine and supplement you take.
Prescription and legal status
United States. No montelukast plus levocetirizine product is approved by the FDA (no match in the FDA's Drugs@FDA and NDC data, searched 28 October 2026). Montelukast is a prescription medicine (Singulair, NDA 020829, and generics). Levocetirizine 5 mg became non-prescription when Xyzal Allergy 24HR (NDA 209089) was approved on 31 January 2017; the older prescription Xyzal tablet (NDA 022064) is listed as discontinued, with a Federal Register determination that it was not withdrawn for safety or effectiveness reasons. The FDA says personal importation of unapproved medicines is illegal in most circumstances, and this Indian pack is not approved by the FDA.
United Kingdom. On the emc (the UK medicines compendium, which is not the full MHRA register), every montelukast and levocetirizine product listed is a prescription only medicine, and we found no montelukast plus levocetirizine product. The UK montelukast 10 mg licence covers seasonal allergic rhinitis only in people with asthma for whom it is indicated. This Indian pack is not authorised by the MHRA.
Canada. Singulair (montelukast) is a prescription drug in the Health Canada Drug Product Database. We found no levocetirizine product, and no montelukast plus levocetirizine product, in the database (searched 28 October 2026).
Australia. Montelukast is Schedule 4 (prescription only) in the Poisons Standard, October 2026. Oral levocetirizine is Schedule 2 (pharmacy medicine), with small hay fever packs for adults and children 12 and over (no more than 5 days' supply, 5 mg a day) unscheduled; Xyzal 5 mg is listed on healthdirect as a pharmacy medicine. We could not search the TGA register (ARTG) directly and have seen no Australian montelukast plus levocetirizine product.
India. Approved by CDSCO for allergic rhinitis in adults (31.01.2008). Tata 1mg and Truemeds mark Montair LC as prescription required. Check the rules where you live.
Buying genuine Montair LC
The MHRA warns that "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have." It advises UK buyers: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo". That warning covers this Indian pack. When your order arrives, read the strip: it should say Montair LC, list montelukast 10 mg and levocetirizine 5 mg, name Cipla, and carry a batch number and expiry date. Tata 1mg, Truemeds and PharmEasy list strips of 15 tablets to be stored below 30 C, protected from light and moisture. These checks cannot prove that tablets are genuine, because counterfeiters copy packaging. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.
Delivery
We ship Montair LC to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days. Shipping costs a flat $25 on orders under $149 and is free from $149. For hay fever that has already started, a local pharmacy is faster. See our shipping page and refund policy.
Related products and guides
For hay fever without montelukast we also list Allegra 180mg (fexofenadine, an antihistamine), Allegra Nasal Spray (fluticasone, a steroid nasal spray) and Olopat Eye Drop (olopatadine, for itchy eyes). For montelukast alone there is Montair 10mg. Ask a doctor or pharmacist which one suits your symptoms.
Sources
- Singulair (montelukast sodium) tablets, chewable tablets and oral granules, US prescribing information, Organon (DailyMed setid 482dcc92-b47f-4ea6-854a-f5ac2aea7842, version 5, effective 30 April 2025; NDA 020829): Boxed Warning, sections 1, 2, 4, 5.1 to 5.5, 6.1 (Table 5), 6.2, 7, 8.1, 8.2, 8.5 to 8.7, 10, 12.3, 14.3. DailyMed
- Singulair 10 mg film-coated tablets, UK Summary of Product Characteristics, Organon Pharma (UK) Limited (PL 00025/0358, revised 31 August 2026): sections 4.1 to 4.9. emc
- Xyzal (levocetirizine dihydrochloride) tablets and oral solution, US prescribing information, Chattem (DailyMed setid 1673f7ff-0c7c-4403-86cf-c05eb1475222, version 2, effective 22 July 2025): sections 2, 4, 5.1 to 5.3, 6.1 (Table 1), 6.2, 7, 8.1 to 8.7, 10, 12.3. DailyMed
- Xyzal Allergy 24HR (levocetirizine dihydrochloride 5 mg), US Drug Facts, Chattem (DailyMed setid 8be45c2a-1eca-4a00-81b9-f7babdbdcd41, version 14, effective 11 March 2026; NDA 209089). DailyMed
- Xyzal 5 mg film-coated tablets, UK Summary of Product Characteristics, UCB Pharma Limited (PL 00039/0539, revised July 2022): sections 4.1 to 4.9. emc
- US Food and Drug Administration. FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis. Drug Safety Communication, 4 March 2020. FDA
- MHRA. Montelukast: reminder of the risk of neuropsychiatric reactions. Drug Safety Update, 29 April 2024. GOV.UK
- Central Drugs Standard Control Organisation (India). Fixed dose combinations approved by DCG(I) since 1961 to 31st December 2019, item 799: "Montelucast 10mg + Levocetirizine 5mg film coated tablets", "For the treatment of allergic rhinitis in adults only", 31.01.08. CDSCO
- Kim et al. Comparative efficacy of montelukast-levocetirizine combination therapy versus monotherapy in allergic rhinitis: a systematic review and meta-analysis. Int Arch Allergy Immunol 2026. PMID 40664175.
- Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC) 2026, file dated 28 October 2026, effective 21 October 2026: montelukast sodium 10 mg tablet $0.04321 (31 NDCs); levocetirizine 5 mg tablet $0.05175 (8 NDCs) and $0.21841 (4 NDCs); Singulair 10 mg tablet $9.22717 (2 NDCs). data.medicaid.gov
- openFDA Drugs@FDA and NDC directory searches for montelukast with levocetirizine (no match), Xyzal (NDA 022064, 209089, 209090) and Singulair (NDA 020829, 020830, 021409), 28 October 2026. openFDA
- Health Canada Drug Product Database: Singulair (Organon Canada), prescription; no levocetirizine product found; searched 28 October 2026. Health Canada
- Therapeutic Goods (Poisons Standard, October 2026) Instrument 2026 (F2026L01327), Schedule 2 and Schedule 4 entries for levocetirizine and Schedule 4 entry for montelukast. Federal Register of Legislation
- healthdirect Australia: Xyzal (levocetirizine 5 mg), Schedule 2. healthdirect
- Indian pharmacy listings for Montair LC Tablet (Tata 1mg, Truemeds, PharmEasy), checked 28 October 2026.
- MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
- US Food and Drug Administration. Personal Importation. FDA
This page is for information and is not medical advice. Montair LC does not treat an asthma attack or a severe allergic reaction. If you have thoughts of harming yourself, swelling of the mouth or throat, or trouble breathing, call emergency services.
Frequently asked questions
What is Montair LC used for?
Montair LC is a Cipla tablet that combines montelukast 10 mg and levocetirizine 5 mg. India's regulator (CDSCO) approved this combination on 31.01.2008 for allergic rhinitis (hay fever and year round nasal allergy) in adults only. It is not a reliever for asthma attacks, and the combination is not approved for asthma in India. Montelukast alone is used for asthma, but as an add on to your inhalers, not instead of them.
Is Montair LC approved in the US, UK, Australia or Canada?
No. As far as we could check, no montelukast plus levocetirizine combination is approved by the FDA, MHRA, TGA or Health Canada. Each ingredient is licensed on its own in the US, UK and Australia; in Canada montelukast is licensed but we found no levocetirizine product. This Indian pack is not registered in any of those countries.
How much does Montair LC cost per tablet?
As of October 2026: $45 for 30 tablets ($1.50 each), $76 for 60 ($1.27) and $96 for 90 ($1.07), before shipping. Shipping is $25 under $149 and free from $149, so with shipping the cost per tablet is $2.33, $1.68 and $1.34. The pack selector shows the current price.
Is it cheaper to buy montelukast and levocetirizine separately in the US?
Yes, much cheaper. In the NADAC file dated 28 October 2026 (effective 21 October 2026), US pharmacies paid $0.04321 for a generic montelukast 10 mg tablet and $0.05175 for most generic levocetirizine 5 mg tablets: about 10 cents a day for both, against $1.07 to $1.50 for one Montair LC tablet from us. Levocetirizine is sold without a prescription in the US, and two separate tablets let your doctor change or stop either one.
How do I take Montair LC?
One tablet once a day, swallowed whole with water, with or without food. The evening suits both ingredients: levocetirizine is labelled for evening use, and the US montelukast label says people with both asthma and allergic rhinitis should take their one dose in the evening. If you miss a dose, take the next one at the usual time; do not take two at once. Do not take it with another montelukast product.
Why does the FDA say montelukast should not be a first choice for hay fever?
Because of serious mental health side effects. In March 2020 the FDA required a boxed warning about neuropsychiatric events, including agitation, aggression, depression, sleep disturbances and suicidal thoughts and behaviour (including suicide). For allergic rhinitis, the FDA said montelukast should be reserved for people who are not treated effectively with, or cannot tolerate, other allergy medicines. If you notice changes in mood, behaviour or sleep, the US label says to stop the medicine and contact a healthcare provider immediately; the UK MHRA says to seek immediate medical attention.
Can I take Montair LC if I have kidney problems?
Usually not. Levocetirizine is cleared by the kidneys. The US over the counter label says do not use it if you have kidney disease, the US prescription label lowers the dose to 2.5 mg even in mild kidney impairment, and the UK label spaces doses out from an eGFR below 60. Levocetirizine is contraindicated in end stage kidney disease or on dialysis. A fixed combination tablet cannot be adjusted this way, so ask your doctor about separate tablets.
Can children take Montair LC?
No. The Indian approval is for adults only, and the montelukast 10 mg tablet is labelled for age 15 and over in the US and UK. The US levocetirizine label says do not use it under 6 and limits children 6 to 11 to 2.5 mg a day. A children's version (Montair LC Kid) exists in India, but a child's dose should be decided by their doctor.
What are the side effects of Montair LC?
From the single ingredient labels: levocetirizine 5 mg caused somnolence in 6% vs 2% on placebo, fatigue 4% vs 2% and dry mouth 2% vs 1% (US label). Montelukast 10 mg trial rates were close to placebo (headache 18.4% vs 18.1%). The serious risks are the montelukast neuropsychiatric events, allergic reactions, liver injury, urinary retention with levocetirizine and itching after stopping long term levocetirizine.
Who should not take Montair LC?
Never take it if you are allergic to montelukast, levocetirizine, cetirizine or any ingredient (the UK levocetirizine label adds hydroxyzine and other piperazine derivatives), or if you have end stage kidney disease or are on dialysis. Ask a doctor first if you have kidney disease, mental health problems, asthma, trouble passing urine, an enlarged prostate, epilepsy, are 65 or over, pregnant or breastfeeding. It is not for children.
Do I need a prescription, and how long does delivery take?
Montelukast is prescription only in the US, UK, Canada and Australia, and Tata 1mg and Truemeds mark Montair LC as prescription required in India. The FDA says personal importation of unapproved medicines is illegal in most circumstances. We ship to the US, UK, Australia and Canada in plain packaging with tracking in 7 to 14 business days; shipping is $25 under $149 and free from $149.
Medical References
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Montair LC? Tell other buyers how it went.







